These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
685 related articles for article (PubMed ID: 30582205)
1. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma. Chen PF; Li QH; Zeng LR; Yang XY; Peng PL; He JH; Fan B J Cell Biochem; 2019 Jun; 120(6):9117-9124. PubMed ID: 30582205 [TBL] [Abstract][Full Text] [Related]
2. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
3. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
4. Seven-senescence-associated gene signature predicts overall survival for Asian patients with hepatocellular carcinoma. Xiang XH; Yang L; Zhang X; Ma XH; Miao RC; Gu JX; Fu YN; Yao Q; Zhang JY; Liu C; Lin T; Qu K World J Gastroenterol; 2019 Apr; 25(14):1715-1728. PubMed ID: 31011256 [TBL] [Abstract][Full Text] [Related]
5. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma. Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592 [TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
7. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma. Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma. Chen S; Zhao E Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631 [TBL] [Abstract][Full Text] [Related]
9. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma. Fang Q; Chen H Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682 [TBL] [Abstract][Full Text] [Related]
10. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma. Yan J; Zhou C; Guo K; Li Q; Wang Z J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981 [TBL] [Abstract][Full Text] [Related]
11. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis. Zhen Z; Shen Z; Hu Y; Sun P Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885 [TBL] [Abstract][Full Text] [Related]
12. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients. Wang Z; Zhang N; Lv J; Ma C; Gu J; Du Y; Qiu Y; Zhang Z; Li M; Jiang Y; Zhao J; Du H; Zhang Z; Lu W; Zhang Y Biomed Res Int; 2020; 2020():4037639. PubMed ID: 33163533 [TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis. Yan Z; He M; He L; Wei L; Zhang Y Front Immunol; 2021; 12():723271. PubMed ID: 34925311 [TBL] [Abstract][Full Text] [Related]
14. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma. Li X; Lin J; Pan Y; Cui P; Xia J Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477 [No Abstract] [Full Text] [Related]
15. Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes. Yan J; Cao J; Chen Z BMC Cancer; 2021 Feb; 21(1):175. PubMed ID: 33602168 [TBL] [Abstract][Full Text] [Related]
16. A six-gene-based prognostic signature for hepatocellular carcinoma overall survival prediction. Wang Z; Teng D; Li Y; Hu Z; Liu L; Zheng H Life Sci; 2018 Jun; 203():83-91. PubMed ID: 29678742 [TBL] [Abstract][Full Text] [Related]
17. A ferroptosis-associated lncRNAs signature predicts the prognosis of hepatocellular carcinoma. Wang D; Zhang L; Zhang Y; Zhang Y; Xu S Medicine (Baltimore); 2022 Jul; 101(28):e29546. PubMed ID: 35839000 [TBL] [Abstract][Full Text] [Related]
18. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma. Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394 [TBL] [Abstract][Full Text] [Related]
20. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data. Yu L; Shen N; Shi Y; Shi X; Fu X; Li S; Zhu B; Yu W; Zhang Y Front Immunol; 2022; 13():1009789. PubMed ID: 36211448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]